Related Experiment Video
Updated: Mar 27, 2026

Facile Preparation of 4-Substituted Quinazoline Derivatives
Published on: February 15, 2016
Development of certain new 2-substituted-quinazolin-4-yl-aminobenzenesulfonamide as potential antitumor agents
Ahmed M Alafeefy1, Rehan Ahmad2, Maha Abdulla2
1DAIS, Alkharj 11942, P.O. Box 217, Saudi Arabia.
Abstract:
Carbonic anhydrases (CA I, II, IX and XII) are known to be highly expressed in various human malignancies. CA IX is overexpressed in colorectal cancer specifically in hereditary nonpolyposis colorectal cancer. Inhibition of CA activity by small molecular CA inhibitor like sulphonamides, sulphonamide derivative (SU.D2) or HIF1a inhibitor Chetomin leads to inhibition of tumorigenesis. Eighteen new quinazolin-4-sulfonamide derivatives were prepared and characterized by means of IR, NMR and mass spectra. Certain selected derivatives were tested for their ability to inhibit four isoforms of the metalloemzyme CA, namely, CA I, CA II, CA IX and CA XII. Compound 3c was found to be highly effective in inhibiting the cancer cell proliferation. 3c decreased cell viability of human HT-29 cells in dose and time dependent manner and with IC50 of 5.45 μM. Moreover, it was tested on metastatic colon cancer cell SW-620 where it was found to be equally effective on human SW-620 cells. This novel compound inhibited the CA IX and CA XII protein expression in HT-29 cells without affecting CA I and CA II expression. These findings indicate that 3c inhibits cellular proliferation in two human colon cancer cells by specifically targeting the CA IX and CA XII expression.
Insights
A novel sulfonamide derivative, compound 3c, effectively inhibits colorectal cancer cell proliferation by targeting carbonic anhydrase IX and XII. This discovery offers a new therapeutic strategy for colon cancer treatment.
Area of Science:
- Biochemistry
- Medicinal Chemistry
- Oncology
Background:
- Carbonic anhydrases (CA I, II, IX, XII) are upregulated in human cancers, particularly CA IX in colorectal cancer.
- Inhibiting carbonic anhydrase activity shows potential for cancer therapy.
Purpose of the Study:
- To synthesize and evaluate new quinazolin-4-sulfonamide derivatives as carbonic anhydrase inhibitors.
- To assess the efficacy of these derivatives against colorectal cancer cell lines.
Main Methods:
- Synthesis and characterization of eighteen new quinazolin-4-sulfonamide derivatives.
- In vitro testing of selected derivatives against CA I, II, IX, and XII isoforms.
- Evaluation of compound 3c's effect on HT-29 and SW-620 cell viability and protein expression.
Main Results:
- Compound 3c demonstrated potent inhibition of colorectal cancer cell proliferation (HT-29 and SW-620).
- 3c decreased cell viability in a dose- and time-dependent manner with an IC50 of 5.45 μM against HT-29 cells.
- 3c specifically inhibited CA IX and CA XII protein expression in HT-29 cells, sparing CA I and CA II.
Conclusions:
- Compound 3c is a promising novel inhibitor targeting CA IX and CA XII.
- This specific inhibition mechanism offers a potential therapeutic avenue for colorectal cancer treatment.
Related Concept Videos
Nucleophilic Aromatic Substitution of Aryldiazonium Salts: Aromatic SN1
In the Sandmeyer reaction, for example, the diazonio group is replaced by a chloro, bromo,...
Diazonium Group Substitution with Halogens and Cyanide: Sandmeyer and Schiemann Reactions
Amines to Sulfonamides: The Hinsberg Test
Generally, a primary amine reacts with the Hinsberg reagent to produce an N-substituted benzenesulfonamide. The electron-withdrawing sulfonyl...
Aryldiazonium Salts to Azo Dyes: Diazo Coupling
Preparation of 1° Amines: Azide Synthesis
Azide ions act as good nucleophiles and react with unhindered alkyl halides to form alkyl azides. Alkyl azides do not participate in further nucleophilic substitution reactions, thereby eliminating the chances of polyalkylated products. Alkyl azides are reduced by hydride-based reducing agents, like lithium aluminum...
Physical Properties of Amines

